chr6-32968658-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_005104.4(BRD2):​c.-1703C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0237 in 153,654 control chromosomes in the GnomAD database, including 63 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.024 ( 63 hom., cov: 33)
Exomes 𝑓: 0.033 ( 0 hom. )

Consequence

BRD2
NM_005104.4 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0370

Publications

2 publications found
Variant links:
Genes affected
BRD2 (HGNC:1103): (bromodomain containing 2) This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene. [provided by RefSeq, Dec 2010]
HLA-DMA (HGNC:4934): (major histocompatibility complex, class II, DM alpha) HLA-DMA belongs to the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DMA) and a beta chain (DMB), both anchored in the membrane. It is located in intracellular vesicles. DM plays a central role in the peptide loading of MHC class II molecules by helping to release the CLIP molecule from the peptide binding site. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and the cytoplasmic tail. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0237 (3603/152316) while in subpopulation SAS AF = 0.039 (188/4824). AF 95% confidence interval is 0.0344. There are 63 homozygotes in GnomAd4. There are 1726 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 63 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRD2NM_005104.4 linkc.-1703C>G 5_prime_UTR_variant Exon 1 of 13 ENST00000374825.9 NP_005095.1
LOC124901302NR_190903.1 linkn.-137G>C upstream_gene_variant
LOC124901302NR_190904.1 linkn.-137G>C upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRD2ENST00000374825.9 linkc.-1703C>G 5_prime_UTR_variant Exon 1 of 13 1 NM_005104.4 ENSP00000363958.4 P25440-1

Frequencies

GnomAD3 genomes
AF:
0.0237
AC:
3603
AN:
152198
Hom.:
63
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00649
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.0245
Gnomad ASJ
AF:
0.0115
Gnomad EAS
AF:
0.0241
Gnomad SAS
AF:
0.0385
Gnomad FIN
AF:
0.0141
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0351
Gnomad OTH
AF:
0.0272
GnomAD4 exome
AF:
0.0329
AC:
44
AN:
1338
Hom.:
0
Cov.:
0
AF XY:
0.0359
AC XY:
37
AN XY:
1030
show subpopulations
African (AFR)
AF:
0.0385
AC:
1
AN:
26
American (AMR)
AF:
0.00
AC:
0
AN:
8
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
6
East Asian (EAS)
AF:
0.0313
AC:
1
AN:
32
South Asian (SAS)
AF:
0.0327
AC:
10
AN:
306
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
20
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
8
European-Non Finnish (NFE)
AF:
0.0337
AC:
30
AN:
890
Other (OTH)
AF:
0.0476
AC:
2
AN:
42
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0237
AC:
3603
AN:
152316
Hom.:
63
Cov.:
33
AF XY:
0.0232
AC XY:
1726
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00647
AC:
269
AN:
41578
American (AMR)
AF:
0.0244
AC:
374
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0115
AC:
40
AN:
3472
East Asian (EAS)
AF:
0.0240
AC:
124
AN:
5170
South Asian (SAS)
AF:
0.0390
AC:
188
AN:
4824
European-Finnish (FIN)
AF:
0.0141
AC:
150
AN:
10616
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0351
AC:
2389
AN:
68024
Other (OTH)
AF:
0.0269
AC:
57
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
185
370
556
741
926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0137
Hom.:
9
Bravo
AF:
0.0233
Asia WGS
AF:
0.0480
AC:
169
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.1
DANN
Benign
0.59
PhyloP100
0.037
PromoterAI
-0.012
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3918150; hg19: chr6-32936435; API